» Articles » PMID: 16651484

Is C-reactive Protein an Innocent Bystander or Proatherogenic Culprit? The Verdict is Still out

Overview
Journal Circulation
Date 2006 May 3
PMID 16651484
Citations 50
Authors
Affiliations
Soon will be listed here.
Citing Articles

C-reactive protein: a target for therapy to reduce inflammation.

Rizo-Tellez S, Sekheri M, Filep J Front Immunol. 2023; 14:1237729.

PMID: 37564640 PMC: 10410079. DOI: 10.3389/fimmu.2023.1237729.


Hypertriglyceridemia: A Neglected Risk Factor for Ischemic Stroke?.

Liang H, Zhang Q, Hu Y, Liu G, Qi R J Stroke. 2022; 24(1):21-40.

PMID: 35135057 PMC: 8829486. DOI: 10.5853/jos.2021.02831.


Apolipoprotein (a)/Lipoprotein(a)-Induced Oxidative-Inflammatory 7-nAChR/p38 MAPK/IL-6/RhoA-GTP Signaling Axis and M1 Macrophage Polarization Modulate Inflammation-Associated Development of Coronary Artery Spasm.

Lin Y, Yeh C, Kuo K, Fong I, Yadav V, Kounis N Oxid Med Cell Longev. 2022; 2022:9964689.

PMID: 35096275 PMC: 8793348. DOI: 10.1155/2022/9964689.


The Effect of Race and Shear Stress on CRP-Induced Responses in Endothelial Cells.

Ling C, Cook M, Grimm H, Aldokhayyil M, Gomez D, Brown M Mediators Inflamm. 2021; 2021:6687250.

PMID: 34899053 PMC: 8660250. DOI: 10.1155/2021/6687250.


C-Reactive Protein Levels and Clinical Prognosis in LAA-Type Stroke Patients: A Prospective Cohort Study.

Zeng Q, Zeng Y, Slevin M, Guo B, Shen Z, Deng B Biomed Res Int. 2021; 2021:6671043.

PMID: 34212039 PMC: 8205586. DOI: 10.1155/2021/6671043.